{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:04:35Z","timestamp":1793675075979,"version":"4.5.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST102-2320-B-077-004-"],"award-info":[{"award-number":["MOST102-2320-B-077-004-"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST100-2313-B-134-001-MY3"],"award-info":[{"award-number":["MOST100-2313-B-134-001-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST103-2313-B-134-001-MY3"],"award-info":[{"award-number":["MOST103-2313-B-134-001-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Institute of Chinese Medicine, Taiwan","award":["NRICM102-DBCM-06-F3"],"award-info":[{"award-number":["NRICM102-DBCM-06-F3"]}]},{"name":"National Research Institute of Chinese Medicine, Taiwan","award":["MOHW103-NRICM-C-305122106"],"award-info":[{"award-number":["MOHW103-NRICM-C-305122106"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.antiviral.2014.09.009","type":"journal-article","created":{"date-parts":[[2014,9,27]],"date-time":"2014-09-27T20:12:15Z","timestamp":1411848735000},"page":"100-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"special_numbering":"C","title":["(\u2212)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes"],"prefix":"10.1016","volume":"111","author":[{"given":"Hsiu-Chen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Hua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Min","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.09.009_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2006.08.018","article-title":"Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes","volume":"46","author":"Aly","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2014.09.009_b0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/bi052202j","article-title":"Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains","volume":"45","author":"Banerjee","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2014.09.009_b0015","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J","article-title":"Hepatitis B virus. The major etiology of hepatocellular carcinoma","volume":"61","author":"Beasley","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.antiviral.2014.09.009_b0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.24803","article-title":"(\u2212)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry","volume":"55","author":"Calland","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.09.009_b0025","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/ctr.12224","article-title":"Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity","volume":"27","author":"Campsen","year":"2013","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.antiviral.2014.09.009_b0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.gt.3302846","article-title":"Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA","volume":"14","author":"Chen","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2014.09.009_b0035","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2174\/0929867024606696","article-title":"Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents","volume":"9","author":"Chen","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.09.009_b0040","first-page":"3312","article-title":"Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals","volume":"9","author":"Chow","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.antiviral.2014.09.009_b0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/281646a0","article-title":"Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli","volume":"281","author":"Galibert","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.09.009_b0050","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u2014natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.09.009_b0055","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2174\/1389557511313050012","article-title":"Small-molecule inhibitors for the treatment of hepatitis B virus documented in patents","volume":"13","author":"Geng","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.09.009_b0060","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s00534-011-0396-3","article-title":"Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids","volume":"18","author":"Gonzalez","year":"2011","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"10.1016\/j.antiviral.2014.09.009_b0065","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.09.009_b0070","doi-asserted-by":"crossref","first-page":"10629","DOI":"10.1073\/pnas.88.23.10629","article-title":"Functional expression cloning and characterization of the hepatocyte Na+\/bile acid cotransport system","volume":"88","author":"Hagenbuch","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.09.009_b0075","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1128\/JVI.75.11.5343-5351.2001","article-title":"Hepatitis B virus large envelope protein interacts with gamma2-adaptin, a clathrin adaptor-related protein","volume":"75","author":"Hartmann-Stuhler","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.009_b0080","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1128\/JVI.00873-12","article-title":"Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis","volume":"86","author":"Huang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.009_b0085","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/AAC.00825-07","article-title":"Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus","volume":"52","author":"Isaacs","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.09.009_b0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jmv.10534","article-title":"Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers","volume":"72","author":"Kao","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.09.009_b0095","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0091-6749(03)02007-4","article-title":"Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding","volume":"112","author":"Kawai","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.antiviral.2014.09.009_b0100","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.antiviral.2013.08.002","article-title":"Inhibition of influenza virus internalization by (\u2212)-epigallocatechin-3-gallate","volume":"100","author":"Kim","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.09.009_b0105","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/j.vaccine.2007.12.008","volume":"26","author":"Kotwal","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.09.009_b0110","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1053\/gast.1997.v113.pm9322525","article-title":"Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas","volume":"113","author":"Kullak-Ublick","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.09.009_b0115","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1940-6207.CAPR-12-0001","article-title":"Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model","volume":"5","author":"Lin","year":"2012","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.antiviral.2014.09.009_b0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"Lutgehetmann","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.09.009_b0125","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.cellbio.12.1.575","article-title":"Endocytosis and molecular sorting","volume":"12","author":"Mellman","year":"1996","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.antiviral.2014.09.009_b0130","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/mthe.2000.0075","article-title":"Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro","volume":"1","author":"Miao","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2014.09.009_b0135","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.09.009_b0140","doi-asserted-by":"crossref","first-page":"9927","DOI":"10.1021\/jf202376u","article-title":"Inhibition of the replication of hepatitis B virus in vitro by pu-erh tea extracts","volume":"59","author":"Pei","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.antiviral.2014.09.009_b0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2014.09.009_b0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00394-010-0164-1","article-title":"Plasma pharmacokinetics of catechin metabolite 4\u2032-O-Me-EGC in healthy humans","volume":"50","author":"Renouf","year":"2011","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.antiviral.2014.09.009_b0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.biochem.66.1.511","article-title":"Clathrin-coated vesicle formation and protein sorting: an integrated process","volume":"66","author":"Schmid","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.antiviral.2014.09.009_b0160","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.09.009_b0165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral effect of catechins in green tea on influenza virus","volume":"68","author":"Song","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.09.009_b0170","doi-asserted-by":"crossref","first-page":"G722","DOI":"10.1152\/ajpgi.00056.2013","article-title":"A dileucine motif is involved in plasma membrane expression and endocytosis of rat sodium taurocholate cotransporting polypeptide (Ntcp)","volume":"305","author":"Stross","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.antiviral.2014.09.009_b0175","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1529\/biophysj.106.097105","article-title":"Single GUV method reveals interaction of tea catechin (\u2212)-epigallocatechin gallate with lipid membranes","volume":"92","author":"Tamba","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.antiviral.2014.09.009_b0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.7150\/ijms.2.114","article-title":"Identification of cellular membrane proteins interacting with hepatitis B surface antigen using yeast split-ubiquitin system","volume":"2","author":"Toh","year":"2005","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.antiviral.2014.09.009_b0185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2009.05.002","article-title":"Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro","volume":"83","author":"Wang","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.09.009_b0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.fct.2007.08.007","article-title":"Validation of green tea polyphenol biomarkers in a phase II human intervention trial","volume":"46","author":"Wang","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.antiviral.2014.09.009_b0195","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3390\/ijms15022892","article-title":"NTCP and beyond: opening the door to unveil hepatitis B virus entry","volume":"15","author":"Watashi","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2014.09.009_b0200","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"issue":"1593\u20131608","key":"10.1016\/j.antiviral.2014.09.009_b0205","first-page":"e1591","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T03:32:36Z","timestamp":1538191956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214002769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":41,"alternative-id":["S0166354214002769"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.09.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(\u2212)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}